A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NU / normal urothelium

[Related PubMed/MEDLINE]
Total Number of Papers: 10
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NU  (>> Co-occurring Abbreviation)
Long Form:   normal urothelium
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2014 Epigenetic inactivation of ST6GAL1 in human bladder cancer. CIS, MSP, pTa
2014 Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections. PUNLMP
2013 Down-regulated claudin-7 immunoexpression in urothelial carcinoma of the urinary bladder. IHC, MI, NMI, UC
2013 Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma. CIS, HGPCa, UC
2013 Karyometry and quantitative immunohistochemical analysis of the urothelium in tissue sections: a feasibility study based on chromatin remodeler DAXX immunostaining. ---
2011 Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis. 5-MeC, IHC, PUNLMP, UC
2011 Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer. me, METs, NMIBC
2008 Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential. 5-MeC, IHC, PUNLMP, UC
2008 Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. CK20, FGFR3, IHC, PUNLMP, UC
10  1998 Molecular mediators of angiogenesis in bladder cancer. CA, TSP-1, VEGF